View Section: Financials
Vaxfab Statements
54
Vaxfab Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2023-09-30
%
60.518
100
54.222
96.2
6.296
3.8
—
0
0.149
0.3
3.643
2.9
2.653
0.9
—
0
1.178
6.2
3.831
7.1
0.958
1.7
2.873
5.3
0.34
8.45
2023-03-31
%
163.57
100
156.12
96.3
7.446
3.7
—
0
0.209
0.1
3.033
1.6
4.413
2.1
0.548
0.4
—
0
4.961
2.5
1.158
0.5
3.804
1.9
4.718
1.532
2022-09-30
%
3.96
100
2.822
73.8
1.138
26.2
—
0
0.042
0.8
1.043
38
0.095
-11.8
-0.003
14.4
—
0
0.092
2.6
—
-0.3
0.093
2.8
0.04
2.192
2022-03-31
%
2.726
100
2.731
59.8
-0.005
40.2
—
0
0.524
8.8
2.065
49.4
-2.07
-9.2
—
0
1.466
24.9
-0.604
15.6
0.009
0.3
-0.613
15.3
-0.259
2.436
2021-09-30
%
—
100
—
0
—
0
—
0
0.238
0
0.618
0
-0.618
0
—
0
0.215
0
-0.403
0
-0.082
0
-0.321
0
-0.23
1.884
View Section: Balance Sheet